Fintrender
IPO · Anthropic · Lock-ups

Anthropic IPO: the next 60 days

Published · Nov 20, 2026Author · Gustavo CunhaRead · 10 minLanguage · EN · PT

In its first session ANT closed at US$97.17, 17% above the US$83 IPO price — almost the same gain as SPCX's first day. Over the next 60 days it will have more insider supply unlocked than SPCX had over the same span: up to 1.26bn insider shares become eligible by 19 January in four tranches, starting on day 1, where SPCX released nothing until day 56 and then 911.5m at once. Index-fund buying is of similar size — ~US$4.6bn estimated for the Nasdaq-100 against SPCX's ~US$4.3bn — but it arrives in December, mixed in with the unlocks, and with no quarterly results in between to change the narrative. Status as of 20 November, before the New York open. Disclosure: the analysis was produced with the help of Claude, an Anthropic model, limited to market data, with no view on the company.

Same structure, different order

The two deals share their skeleton: a small float; a staggered 180-day lock-up with founders held for a year (Musk to June 2027, Anthropic's seven co-founders up to 365 days); fast entry into the Nasdaq-100 with no S&P 500, which kept its 12-month and GAAP-profit tests for both; and above-normal retail allocations. What differs is the sequence. SPCX had one concentrated supply shock, cushioned by its first results, with all passive buying arriving before it. ANT has supply trickling in from day one and similar-sized passive buying that lands in December, mixed in with the unlocks.

What supports ANT: estimated passive buying above US$19bn across indexes, concentrated in December; ~6× IPO demand with a 147m greenshoe still open; and US$26bn of Class N restricted for six months for non-affiliates. What weighs on it: unlocks from day 1, totalling 0.9× the float by 5 Jan; a day one that gave back half its gain and a ~6% drop in the second session's pre-market (20 Nov), amid an AI-stock selloff; and no results within the horizon to change the narrative.

Method: 60 calendar days from pricing (18 Nov 2026 → 17 Jan 2027); days counted from the prospectus date (11 Jun for SPCX, 18 Nov for ANT); unlock volumes are prospectus maximums, not actual sales; ANT index dates are expected and had not been confirmed by the providers as of 20 Nov; ANT's equivalent path is our own calculation (US$83 × SPCX close ÷ US$135), not a forecast. This analysis was produced with the help of Claude, an Anthropic model — a company covered in this report — and is limited to market data.

Key findings

  1. Supply trickles from day 1. Up to 316m insider shares were sellable from the first session, followed by 299m on 15 Dec, 299m on 5 Jan and 349m on 19 Jan (day 62) — 0.9× the 980m IPO float by 5 Jan and 1.3× by 19 Jan. SPCX stayed locked until day 56 and then released 911.5m at once, 1.4× its float, two sessions after its first results. Volumes are prospectus maximums, not actual sales.
  2. More demand, less retail. Anthropic drew about 6× the offering, driven by anchor-sized orders, against ~3.5–4× for SpaceX, and gave retail ~15% against SpaceX's low 20s %. A 30-day greenshoe for up to 147m shares stays open to 18 Dec, and a US$26bn private placement of non-voting Class N, bought by seven companies, sits outside the float with a six-month resale restriction for non-affiliates. Both floats are small — about 5% (SPCX) and 7% (ANT) of total shares — which amplifies every unlock and every index purchase.
  3. Same passive buying, different timing. Indexes weight a stock by its free-floating shares, and the two floats are worth about the same (~US$86bn SPCX with greenshoe, ~US$81bn ANT), so Nasdaq-100 estimates are close: ~US$4.6bn for ANT, ~US$4.3bn for SPCX. ANT's 7th session (30 Nov) falls on the reference date for December's annual reconstitution, which pushes its Nasdaq-100 entry to the open of 21 Dec (day 33) — after the 15 Dec unlock. SPCX entered on day 26, before any unlock. The 'over US$19bn' figure for ANT adds several indexes and should not be compared with SPCX's Nasdaq-100-only US$4.3bn.
  4. SPCX made a full round trip in 60 days. It closed day one at US$160.95, set a record close of US$201.80 on 16 June (+49%), fell ~15% in its first six sessions inside the Nasdaq-100, hit a lowest close of US$108.27 on 5 August (−20%) and was back above US$135 on 10 August, after its first results and first unlock. On the same multiples from US$83, ANT would peak near US$124 around 23 Nov, bottom near US$67 between 11 and 13 Jan and end the 60 days near US$85.
  5. That map is fragile, for three reasons. Day-one euphoria was already sold: ANT opened at 1.34× the IPO price and closed at 1.17×, while SPCX opened at 1.11× and closed at the day's high. The catalyst for SPCX's turn — its first results on 4 Aug — has no equivalent here: ANT has no results expected within the 60 days. And the order of events is reversed, with unlocks before the index. A reference exercise, not a projection.

Report details

TitleAnthropic IPO: the next 60 days
TypeLong-form report
PublishedNov 20, 2026
AuthorGustavo Cunha · Fintrender
FormatPDF · 390 KB · English · Portuguese
Topicsipoanthropicspacexlock-upsindexes
(→)

Read next